Viking Fund Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.51M | Hold |
5,000
| – | – | 0.22% | 96 |
|
|
2026
Q1 | $2.46M | Hold |
5,000
| – | – | 0.25% | 102 |
|
|
2025
Q4 | $2.9M | Hold |
5,000
| – | – | 0.34% | 89 |
|
|
2025
Q3 | $2.43M | Hold |
5,000
| – | – | 0.29% | 94 |
|
|
2025
Q2 | $2.03M | Hold |
5,000
| – | – | 0.28% | 95 |
|
|
2025
Q1 | $2.49M | Hold |
5,000
| – | – | 0.36% | 85 |
|
|
2024
Q4 | $2.6M | Hold |
5,000
| – | – | 0.41% | 80 |
|
|
2024
Q3 | $3.09M | Hold |
5,000
| – | – | 0.5% | 66 |
|
|
2024
Q2 | $2.77M | Hold |
5,000
| – | – | 0.5% | 69 |
|
|
2024
Q1 | $2.91M | Hold |
5,000
| – | – | 0.53% | 66 |
|
|
2023
Q4 | $2.65M | Hold |
5,000
| – | – | 0.52% | 70 |
|
|
2023
Q3 | $2.53M | Hold |
5,000
| – | – | 0.51% | 71 |
|
|
2023
Q2 | $2.61M | Hold |
5,000
| – | – | 0.49% | 71 |
|
|
2023
Q1 | $2.88M | Hold |
5,000
| – | – | 0.55% | 68 |
|
|
2022
Q4 | $2.75M | Hold |
5,000
| – | – | 0.55% | 68 |
|
|
2022
Q3 | $2.54M | Hold |
5,000
| – | – | 0.6% | 63 |
|
|
2022
Q2 | $2.72M | Hold |
5,000
| – | – | 0.63% | 54 |
|
|
2022
Q1 | $2.95M | Hold |
5,000
| – | – | 0.67% | 51 |
|
|
2021
Q4 | $3.34M | Hold |
5,000
| – | – | 0.88% | 35 |
|
|
2021
Q3 | $2.86M | Hold |
5,000
| – | – | 0.83% | 37 |
|
|
2021
Q2 | $2.52M | Hold |
5,000
| – | – | 0.72% | 52 |
|
|
2021
Q1 | $2.28M | Hold |
5,000
| – | – | 0.68% | 53 |
|
|
2020
Q4 | $2.33M | Hold |
5,000
| – | – | 0.75% | 50 |
|
|
2020
Q3 | $2.21M | Hold |
5,000
| – | – | 0.82% | 45 |
|
|
2020
Q2 | $1.81M | Hold |
5,000
| – | – | 0.67% | 51 |
|
|
2020
Q1 | $1.42M | Hold |
5,000
| – | – | 0.62% | 53 |
|
|
2019
Q4 | $1.62M | Hold |
5,000
| – | – | 0.46% | 66 |
|
|
2019
Q3 | $1.46M | Hold |
5,000
| – | – | 0.42% | 66 |
|
|
2019
Q2 | $1.47M | Hold |
5,000
| – | – | 0.39% | 70 |
|
|
2019
Q1 | $1.37M | Hold |
5,000
| – | – | 0.34% | 75 |
|
|
2018
Q4 | $1.12M | Sell |
5,000
-2,000
| -29% | -$469K | 0.31% | 82 |
|
|
2018
Q3 | $1.71M | Sell |
7,000
-1,000
| -13% | -$230K | 0.35% | 74 |
|
|
2018
Q2 | $1.66M | Hold |
8,000
| – | – | 0.32% | 76 |
|
|
2018
Q1 | $1.65M | Sell |
8,000
-500
| -6% | -$105K | 0.31% | 76 |
|
|
2017
Q4 | $1.61M | Hold |
8,500
| – | – | 0.26% | 77 |
|
|
2017
Q3 | $1.61M | Hold |
8,500
| – | – | 0.26% | 77 |
|
|
2017
Q2 | $1.48M | Hold |
8,500
| – | – | 0.23% | 83 |
|
|
2017
Q1 | $1.31M | Hold |
8,500
| – | – | 0.17% | 93 |
|
|
2016
Q4 | $1.2M | Buy |
+8,500
| New | +$1.25M | 0.15% | 87 |
|
Other funds holding TMO
LT
CF
SP
DLA
PL
HPC
Viking Fund Management's TMO Position: Q2 2026 in Review
Viking Fund Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 5,000 shares worth $2.51M. The position accounts for 0.22% of the portfolio, ranked #96.
Viking Fund Management first reported a position in TMO in Q4 2016 and has held it in 39 quarters since. The position peaked at $3.34M in Q4 2021. 409 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Viking Fund Management held 5,000 shares of Thermo Fisher Scientific worth $2.51M as of Q2 2026.
- Viking Fund Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.22% of Viking Fund Management's portfolio in Q2 2026, its #96 holding.
- Viking Fund Management first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 39 quarters since.
- Viking Fund Management's Thermo Fisher Scientific position peaked at $3.34M in Q4 2021.
- 409 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Viking Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.